FDA advisers recommend 1st Candida treatment in over a decade
Erica Carbajal – Thursday, January 26th, 2023 The FDA’s advisory committee on antimicrobial drugs on Jan. 25 recommended rezafungin be approved to treat candidemia and invasive candidiasis in adults with limited or no alternative treatment option. If approved, it would mark the first new drug approval to treat the infections in more than a decade, according to Cidara Therapeutics, […]
FDA advisers recommend 1st Candida treatment in over a decade Read More »